Cite
Werner JM, Weller J, Ceccon G, et al. Diagnosis of Pseudoprogression Following Lomustine-Temozolomide Chemoradiation in Newly Diagnosed Glioblastoma Patients Using FET-PET. Clin Cancer Res. 2021;27(13):3704-3713doi: 10.1158/1078-0432.CCR-21-0471.
Werner, J. M., Weller, J., Ceccon, G., Schaub, C., Tscherpel, C., Lohmann, P., Bauer, E. K., Schäfer, N., Stoffels, G., Baues, C., Celik, E., Marnitz, S., Kabbasch, C., Gielen, G. H., Fink, G. R., Langen, K. J., Herrlinger, U., & Galldiks, N. (2021). Diagnosis of Pseudoprogression Following Lomustine-Temozolomide Chemoradiation in Newly Diagnosed Glioblastoma Patients Using FET-PET. Clinical cancer research : an official journal of the American Association for Cancer Research, 27(13), 3704-3713. https://doi.org/10.1158/1078-0432.CCR-21-0471
Werner, Jan-Michael, et al. "Diagnosis of Pseudoprogression Following Lomustine-Temozolomide Chemoradiation in Newly Diagnosed Glioblastoma Patients Using FET-PET." Clinical cancer research : an official journal of the American Association for Cancer Research vol. 27,13 (2021): 3704-3713. doi: https://doi.org/10.1158/1078-0432.CCR-21-0471
Werner JM, Weller J, Ceccon G, Schaub C, Tscherpel C, Lohmann P, Bauer EK, Schäfer N, Stoffels G, Baues C, Celik E, Marnitz S, Kabbasch C, Gielen GH, Fink GR, Langen KJ, Herrlinger U, Galldiks N. Diagnosis of Pseudoprogression Following Lomustine-Temozolomide Chemoradiation in Newly Diagnosed Glioblastoma Patients Using FET-PET. Clin Cancer Res. 2021 Jul 01;27(13):3704-3713. doi: 10.1158/1078-0432.CCR-21-0471. Epub 2021 May 04. PMID: 33947699.
Copy
Download .nbib